Annual Financials for Decision Diagnostics Corp.
Fiscal year is January-December. All values USD millions. |
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
Sales/Revenue
|
725,484 | 1.88M | 2.24M | 2.38M | 1.98M | |
Sales Growth |
- | 159.19% | 18.91% | 6.41% | -16.82% | |
Cost of Goods Sold (COGS) incl. D&A |
476,718 | 1.95M | 1.93M | 1.95M | 1.78M | |
COGS excluding D&A |
476,718 | 1.95M | 1.93M | 1.95M | 1.78M | |
Depreciation & Amortization Expense |
- | - | - | - | - | |
Depreciation |
- | - | - | - | - | |
Amortization of Intangibles |
- | - | - | - | - | |
COGS Growth |
- | 309.06% | -1.09% | 0.86% | -8.46% | |
Gross Income |
248,766 | (69,659) | 307,197 | 433,825 | 198,260 | |
Gross Income Growth |
- | -128.00% | 541.00% | 41.22% | -54.30% | |
Gross Profit Margin |
- | - | - | - | 10.02% | NA |
|
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
SG&A Expense |
2.87M | 2.29M | 2.16M | 1.73M | 2.31M | |
Research & Development |
- | - | - | - | - | |
Other SG&A |
2.87M | 2.29M | 2.16M | 1.73M | 2.31M | |
SGA Growth |
- | -20.16% | -5.86% | -20.00% | 33.65% | |
Other Operating Expense |
- | - | - | - | 304,280 | |
Unusual Expense |
- | 176,137 | - | - | (10,000) | |
EBIT after Unusual Expense |
- | (2.54M) | - | - | (2.41M) | |
Non Operating Income/Expense |
757,260 | (98,220) | (900) | 1.18M | - | |
Non-Operating Interest Income |
- | - | - | - | - | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
1.1M | 350,087 | 386,087 | 3.02M | 27.26M | |
Interest Expense Growth |
- | -68.07% | 10.28% | 681.06% | 804.08% | |
Gross Interest Expense |
1.1M | 350,087 | 386,087 | 3.02M | 27.26M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
(2.96M) | (2.99M) | (2.24M) | (3.13M) | (29.67M) | |
Pretax Income Growth |
- | -0.81% | 25.05% | -39.83% | -847.10% | |
Pretax Margin |
- | - | - | - | -1,498.91% | NA |
Income Tax |
2,400 | 2,400 | 70 | - | 2,728 | |
Income Tax - Current Domestic |
- | - | - | - | - | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
- | - | - | - | - | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(2.97M) | (2.99M) | (2.24M) | (3.13M) | (29.67M) | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
(2.97M) | (2.99M) | (2.24M) | (3.13M) | (29.67M) | |
Net Income Growth |
- | -0.81% | 25.11% | -39.82% | -847.18% | |
Net Margin Growth |
- | - | - | - | -1,499.05% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
(2.97M) | (2.99M) | (2.24M) | (3.13M) | (29.67M) | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
(2.97M) | (2.99M) | (2.24M) | (3.13M) | (29.67M) | |
EPS (Basic) |
(0.04) | (0.03) | (0.02) | (0.02) | (0.11) | |
EPS (Basic) Growth |
- | 25.00% | 40.33% | -16.20% | -435.10% | |
Basic Shares Outstanding |
66.45M | 94.24M | 124.99M | 150.37M | 266.56M | |
EPS (Diluted) |
(0.04) | (0.03) | (0.02) | (0.02) | (0.11) | |
EPS (Diluted) Growth |
- | 25.00% | 40.33% | -16.20% | -435.10% | |
Diluted Shares Outstanding |
66.45M | 94.24M | 124.99M | 150.37M | 266.56M | |
EBITDA |
- | - | (1.85M) | (1.29M) | (2.42M) | |
EBITDA Growth |
- | - | - | 30.15% | -86.63% | |
EBITDA Margin |
- | - | - | - | -122.06% | NA |